Since pooled estimates based on meta-analysis have proven to be useful in determining the overall risk of certain IBD polymorphisms when results of individual studies are inconsistent [10], we decided to perform the present meta-analysis in order to clarify the association between the MIF -173G/C polymorphism and IBD risk. This evidence concerns the gene MIF and inflammatory bowel disease.